Daily Oncology News

70-Gene signature not likely to be cost-effective for breast cancer

70-Gene signature not likely to be cost-effective for breast cancer

Findings in comparative economic analysis of patients with node-negative breast cancer showed the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making.

Many clinicians feel mobile apps can improve patient outcomes

Many clinicians feel mobile apps can improve patient outcomes

Many physicians believe digital communication technologies, including mobile apps, can be of benefit to their patients.

Overdetection of PSA recurrence after radical prostatectomy more likely in older patients

Overdetection of PSA recurrence after radical prostatectomy more likely in older patients

For some men, prostate cancer recurrence may be overdetected, especially in those aged over 70.

Medicare subsidy program helps breast cancer patients afford treatment

Medicare subsidy program helps breast cancer patients afford treatment

'Extra Help' program allows more women of varying racial and ethnic backgrounds to continue their hormone therapy.

Nearly 5 percent of cancer patients die a month after surgery

Nearly 5 percent of cancer patients die a month after surgery

In a study of more than 1.1 million cancer patients who had surgery, almost 5 percent died within one month of their operation. Lack of access to quality care a major factor in these deaths, researchers say.

CT screening for lung cancer for Medicare beneficiaries discussed

CT screening for lung cancer for Medicare beneficiaries discussed

The pros and cons of low-dose computed tomography (CT) screening for lung cancer are evlauated in relation to the Centers for Medicaid & Medicare Services (CMS) evaluation of screening coverage.

Elevated cholesterol associated with prostate cancer recurrence

Elevated cholesterol associated with prostate cancer recurrence

Findings suggest that elevated levels of cholesterol and triglycerides may be linked with greater risk of the prostate cancer recurrence, but normalization of blood fats may reduce risk.

Laxative type might alter colorectal cancer risk

Laxative type might alter colorectal cancer risk

Fiber-based formulations seem to lower the odds for developing colorectal cancer, non-fiber products seem to raise them.

Ovarian cancer mutations may be detected in vaginal fluid

Ovarian cancer mutations may be detected in vaginal fluid

Preliminary finding may bring doctors one step closer to and ovarian cancer screening test.

Cancer diagnosis often adversely affects mental health

Cancer diagnosis often adversely affects mental health

Patients diagnosed with breast cancer, head and neck cancer, and malignant melanoma are particularly at risk for disorders such as anxiety or depression.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs